自由呼吸动态T1加权序列在存在运动伪影风险患者接受钆塞酸增强肝脏MRI中的表现
回顾性纳入两家机构360例接受自由呼吸动态T1WI肝脏MRI的患者,比较笛卡尔序列(XD-VIBE)与自门控径向序列(SG-GRASP)的图像质量和病灶检出。两种序列总体图像质量无显著差异,实际召回率0.6%(2/360),病灶检出率与肝细胞癌诊断性能无显著差异。
要点
- 自由呼吸动态T1WI总体图像质量在平扫、动脉期、门静脉期分别为3.4±0.4、3.2±0.4、3.5±0.4。
- SG-GRASP组各期运动伪影少于XD-VIBE组,但条纹伪影更多(均p<0.001)。
- 两种序列病灶检出率无显著差异(FOM 0.67 vs 0.68,p=0.876),肝细胞癌诊断性能也无显著差异(FOM 0.55 vs 0.62,p=0.105)。
核心结论
- XD-VIBE与SG-GRASP两种自由呼吸动态T1WI序列对存在运动伪影风险的患者均能提供足够图像质量,序列间图像质量与病灶检出率无显著差异。
研究设计与样本
- 回顾性研究,纳入两家机构360例接受钆塞酸增强肝脏MRI自由呼吸动态T1WI的患者,其中XD-VIBE组253例、SG-GRASP组107例;由4名放射科医生独立按4分制评估图像质量、条纹伪影和运动伪影,肝脏病灶按LI-RADS v2018标注和评估。
关键影像表现/征象
- 自由呼吸T1WI总体图像质量在平扫、动脉期、门静脉期分别为3.4±0.4、3.2±0.4、3.5±0.4。
- SG-GRASP组在所有期相的运动伪影均少于XD-VIBE组,而条纹伪影多于XD-VIBE组(均p<0.001)。
- 动脉期总体图像质量两组均为3.2±0.4(p=0.607),门静脉期XD-VIBE组3.5±0.4、SG-GRASP组3.4±0.4(p=0.214),均无显著差异。
诊断标准与关键数值
- 图像质量、条纹伪影和运动伪影采用4分制评估。
- 肝脏病灶按LI-RADS v2018标注和评估。
- 病灶检出率以品质因数(FOM)表示:XD-VIBE组0.67 vs SG-GRASP组0.68(p=0.876),无显著差异。
- 肝细胞癌诊断性能FOM:XD-VIBE组0.55 vs SG-GRASP组0.62(p=0.105),无显著差异。
- 实际召回率0.6%(2/360),不可诊断检查仅0.3%(1/360)。
临床应用与阅片要点
- 对存在运动伪影风险的患者,自由呼吸动态T1WI(XD-VIBE或SG-GRASP)可获得足够图像质量,序列间图像质量和病灶检出率无显著差异。
- SG-GRASP较XD-VIBE运动伪影更少但条纹伪影更多,阅片时需结合伪影类型判断图像可用性。
- 实际召回率仅0.6%(2/360),不可诊断检查仅0.3%(1/360)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the recall rate and performance of free-breathing T1W dynamic imaging in patients who underwent gadoxetic acid-enhanced liver MRI.
METHODS: We retrospectively reviewed patients who underwent free-breathing dynamic T1WI liver MRI using Cartesian (XD-VIBE) or self-gated radial (SG-GRASP) sequences at two institutions. Four radiologists independently reviewed the overall image quality, streak, and motion artifacts for precontrast, arterial, and portal venous phases on a 4-point scale. Hepatic observations were annotated and assessed according to LI-RADS v2018.
RESULTS: In total, 360 patients were included (XD-VIBE [n = 253], SG-GRASP [n = 107]). The overall image quality of free-breathing T1WI was 3.4 ± 0.4, 3.2 ± 0.4, and 3.5 ± 0.4 for precontrast, arterial, and portal venous phases, respectively. The actual recall rate was 0.6% (2/360). The SG-GRASP group showed fewer motion artifacts and more streak artifacts than the XD-VIBE group in all phases (p < 0.001 for all). The overall image quality was not significantly different between the two sequences in arterial (3.2 ± 0.4 in both, p = 0.607) and portal venous phases (3.5 ± 0.4 in XD-VIBE, 3.4 ± 0.4 in SG-GRASP, p = 0.214). Two sequences did not show significant differences in the lesion detection rate (figure of merit, FOM: 0.67 vs. 0.68, p = 0.876) or diagnostic performance for hepatocellular carcinoma (FOM: 0.55 vs. 0.62, p = 0.105).
CONCLUSIONS: Both XD-VIBE and SG-GRASP provided sufficient image quality for patients at risk of developing motion artifacts, without significant differences in image quality or the lesion detection rate between sequences.
KEY POINTS: • The overall image quality of free-breathing T1-weighted images using Cartesian or radial sequences was 3.4 ± 0.4, 3.2 ± 0.4, and 3.5 ± 0.4 for precontrast, arterial, and portal venous phases, respectively. • Only 0.3% (1/360) had undiagnostic exams and the actual recall rate was 0.6% (2/360) in patients who underwent free-breathing dynamic T1WI. • The overall lesion detection rate was 0.67 without a significant difference between Cartesian and radial sequences (figure of merit: 0.67 vs. 0.68, respectively, p = 0.876).
引用
- Park SH, Yoon JH, Park JY, et al. Performance of free-breathing dynamic T1-weighted sequences in patients at risk of developing motion artifacts undergoing gadoxetic acid-enhanced liver MRI. Eur Radiol. 2022. PMID: 36512042. doi:10.1007/s00330-022-09336-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。